Shopping Cart
Remove All
Your shopping cart is currently empty
CDK2/MDM2-IN-1 (III-13) is a dual inhibitor targeting both CDK2 and MDM2, exhibiting an IC50 value of 2.60 nM against CDK2, and demonstrating antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | CDK2/MDM2-IN-1 (III-13) is a dual inhibitor targeting both CDK2 and MDM2, exhibiting an IC50 value of 2.60 nM against CDK2, and demonstrating antitumor activity. |
| In vitro | CDK2/MDM2-IN-1 (100, 200 nM, 4 h) inhibits tumor cell proliferation via the CDK2/p-Rb and MDM2/p53 pathways. |
| In vivo | Administered intraperitoneally at doses of 25 or 50 mg/kg for 14 consecutive days, CDK2/MDM2-IN-1 significantly inhibits the proliferation of colon tumor cells in mice without affecting their body weight. |
| Formula | C26H33N5O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.